Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD crawled time : 00:00 save search
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.02%
H: 1.03%
C: 0.96%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.11%
H: 0.59%
C: 0.1%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.48%
H: 0.31%
C: 0.13%
reach cancer treatment global market
Long-Term Data for Kite’s Yescarta® CAR T-Cell Therapy Presented at ASH 2023 Demonstrate High Rate of Durable Response in Patients With High-Risk Large B-Cell Lymphoma
Published: 2023-12-11 (Crawled : 00:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.77%
H: 1.52%
C: 0.58%
yescarta t-cell response therapy
Xencor Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.05%
H: 1.41%
C: 0.82%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: -1.47%
H: 11.57%
C: 5.97%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.09%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.09%
H: 0.35%
C: -0.57%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.05%
H: 0.38%
C: -0.68%
financial results
MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
Published: 2023-11-06 (Crawled : 00:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
MGNX | $15.7 -3.27% -3.38% 520K
|
Health Technology
|
| O: 1.69%
H: 2.96%
C: 0.74%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.1%
H: 0.38%
C: -0.65%
update financial results
Twice-Yearly Lenacapavir Demonstrates Sustained Impact on Health-Related Quality of Life in People With HIV
Published: 2023-07-24 (Crawled : 00:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.02%
H: 0.45%
C: -2.71%
life hiv impact
Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published: 2023-05-31 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.24%
H: 2.1%
C: 2.1%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.0%
H: 0.66%
C: 0.33%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 0.42%
H: 0.83%
C: -0.41%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.34%
H: 0.32%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.24%
H: 1.43%
C: 0.84%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.03%
H: 0.41%
C: 0.34%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: -1.35%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.09%
H: 0.97%
C: 0.89%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -1.72%
report treatment global hiv therapy growth market
Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
Published: 2023-04-26 (Crawled : 00:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.58%
H: 0.21%
C: -0.59%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -0.08%
H: 2.5%
C: 2.11%
active program
Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company
Published: 2023-03-12 (Crawled : 00:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.18%
H: 3.44%
C: 1.2%
impact
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
Published: 2023-03-09 (Crawled : 00:00) - globenewswire.com
GRTS | $0.8199 11.01% 9.92% 1.9M
|
Health Technology
|
| O: 6.06%
H: 0.0%
C: -13.06%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.09%
H: 1.63%
C: 0.61%
year financial results
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.19%
H: 0.9%
C: -0.35%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -8.03%
H: 0.95%
C: 0.75%
disease topline trial results
AIDS Walk Los Angeles Returns In-Person on October 16 in West Hollywood
Published: 2022-09-08 (Crawled : 00:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.18%
H: 1.22%
C: 0.46%
angeles
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories
Published: 2022-08-15 (Crawled : 00:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.08%
H: 0.39%
C: 0.26%
sciences trodelvy agreement
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published: 2021-08-26 (Crawled : 00:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.17%
H: 1.6%
C: -0.04%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 0.65%
H: 5.79%
C: 4.5%
merge bioscience
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-07-23 (Crawled : 00:00) - fda.gov
XERS | $1.765 -0.84% -0.85% 710K
|
Health Technology
| Email alert
Add to watchlist
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
| Email alert
Add to watchlist
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
| Email alert
Add to watchlist
OTIC | $0.077
|
Health Technology
| Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.765 -0.84% -0.85% 710K
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-24 (Crawled : 00:00) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.33%
H: 0.15%
C: -0.67%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 0.01%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.33%
H: 1.03%
C: 0.03%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.19%
C: -0.58%
XERS | $1.765 -0.84% -0.85% 710K
|
Health Technology
|
| O: -1.15%
H: 1.46%
C: -4.66%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.82%
OTIC | $0.077
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -7.2%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 0.94%
H: 1.4%
C: 1.06%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.51%
H: 0.2%
C: -2.42%
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
|
| O: 0.43%
H: 1.44%
C: -2.16%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.18%
H: 1.17%
C: -1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-04-12 (Crawled : 00:00) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.33%
H: 1.52%
C: 1.34%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.57%
H: 0.28%
C: -0.88%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.13%
H: 0.39%
C: 0.26%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.26%
H: 0.7%
C: 0.4%
XERS | $1.765 -0.84% -0.85% 710K
|
Health Technology
|
| O: -0.47%
H: 0.12%
C: -6.65%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.33%
H: 0.12%
C: -0.69%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -1.86%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 0.9%
C: -0.45%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.13%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.08%
H: 0.08%
C: -0.61%
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
|
| O: -0.59%
H: 0.1%
C: -6.4%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.17%
H: 0.6%
C: 0.17%
Gilead Sciences Announces 4.4 Percent Increase in First Quarter 2021 Dividend
Published: 2021-02-04 (Crawled : 00:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.57%
H: 1.7%
C: 1.45%
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
Published: 2020-12-21 (Crawled : 00:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.07%
H: 0.27%
C: 0.15%
j.p. morgan healthcare conference
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.